INSIGHTS ON DRUG DEVELOPMENT

• The Benefits Of Incorporating Lean Methodologies Into Project Management

  Delve into the core principles of lean project management and explore how these principles can be integrated with traditional methods to enhance project outcomes.

• Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery

  Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

• Method Development For Forced Degradation Of GLP-1 Agonist

  Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.

• Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit

  Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.

• Assessing Particle Generation In A Single-Use Mixing System

  11/13/2025

  Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  3/31/2025

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

• Matrix Approach Enhances Potency Assay Development For ATMPs

  12/22/2025

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• Accelerating Discovery Success With Structure-Guided Drug Design

  5/6/2026

  Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.

• Screening For Amorphous Drug Substance

  5/6/2026

  Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.